banner

Stop youth smoking with JLABS

Find a way to prevent young people from getting addicted to cigarette smoking and you could end up partnering with Johnson & Johnson Innovation, JLABS and Janssen Pharmaceutica.

Cigarette smoking is the number one risk factor for lung cancer. While many solutions and initiatives exist to help addicted smokers kick the habit, more effort is needed to prevent young people from taking up the habit and developing an addiction in the first place.

 

Most existing smoking cessation techniques such as nicotine patches and e-cigarettes may not be as helpful for young people who are at risk for taking up smoking or have just started experimenting with smoking due to peer pressure, since they have not yet developed a serious nicotine addiction. For example, while e-cigarettes may be a “solution” for long-term, heavy smokers, for young people such well-marketed solutions may create a nicotine addiction that was not there to begin with, and thereby create a path to cigarette smoking.

 

Therefore, we challenge you to develop new solutions or initiatives that specifically target young people who are at risk of starting smoking or who have only recently started experimenting with smoking and hence have not yet developed a nicotine addiction. This challenge is contributed by Johnson & Johnson Innovation, JLABS and Janssen.

Event Details

Date:

Thursday, March 28, 2019 - Saturday, March 30, 2019

Location:

Tour & Taxis, Brussels

Language:

English

Organiser(s):

Johnson & Johnson Innovation, JLABS (JLABS) and Janssen Pharmaceutica

2019-03-28 08:00:00 2019-03-30 18:30:00 Europe/Brussels Stop youth smoking with JLABS Tour &amp; Taxis, Brussels <p>Johnson &amp; Johnson Innovation, JLABS (JLABS) and Janssen Pharmaceutica</p>

Interested in a regular update of the Life Sciences and biotech sector in Flanders?